share_log

Bio-Techne And Nikon Instruments Inc. Announce Partnership To Expand Access To Innovative Spatial Biology Services

Benzinga ·  Mar 28 09:09

Bio-Techne Corporation (NASDAQ:TECH) is pleased to announce that Lunaphore, part of Bio-Techne's Spatial Biology Division, is partnering with Nikon Instruments Inc. (Nikon) to expand access to spatial biology services with the COMET platform for US-based biotech, pharma, and academic customers.

Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities, which performs protein detection with standard, non-conjugated antibodies. The Nikon BioImaging Lab is a research and innovation hub recently established by Nikon in the Greater Boston area, Massachusetts with the overarching mission of providing contract imaging solutions, AI-enhanced analysis and bioassay development services to foster research and drug discovery. Together, Lunaphore and the Nikon BioImaging Lab will be able to leverage their complementary expertise in microscopy-based imaging and analysis to bring COMET technology and spatial biology to the greater scientific community.

Through this partnership, in addition to access to the COMET platform, Nikon customers will also benefit from HORIZON, Lunaphore's image analysis software designed for analyzing COMET hyperplex images, to further streamline image analysis workflow. Researchers and clinicians can leverage the universal end-to-end product suite to unlock the full potential of spatial biology for their research objectives.

"The deployment of COMET at the Nikon BioImaging Lab ensures that an expanded base of customers and researchers across the US can access the cutting-edge capabilities of our spatial biology solutions," said Matt McManus, President of Bio-Techne's Diagnostics & Genomics Segment. "This strategic partnership reflects Bio-Techne and Nikon's shared commitment to bringing outstanding innovation to scientists and helping push the boundaries of research."

"Nikon is very excited to have a strategic partnership with Lunaphore," said Toshisada Matsuba, President, CEO at Nikon Instruments Inc.

"We are pleased to provide spatial biology assay services using Lunaphore's automated platform for hyperplex immunofluorescence alongside the broad range of imaging solutions we offer with our Nikon microscopes," added Fumiki Yanagawa, General Manager at the Nikon BioImaging Lab. "Spatial biology is a dynamic area of innovation that will shed new light on healthcare and further our understanding of human disease and health."

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment